HomeInsightsMarket Capitalization

Market Capitalization of Alembic Pharmaceuticals Ltd

Market Capitalization of Alembic Pharmaceuticals Ltd

stocks purchased

₹ 0.8 Cr

Volume transacted

stocks purchased

7.1 K

stocks traded

Last Updated time: 05 Nov 9.00 AM

Image

Alembic Pharmaceuticals Ltd

NSE: APLLTD

MARKETCAP

22106.47 crore

Last updated on: Nov 04, 2024

Key Highlights

  • The Market Cap of Alembic Pharmaceuticals Ltd is ₹ 22106 crore as of 04 Nov 24.
  • The Market Cap of Alembic Pharmaceuticals Ltd changed from ₹ 10000 crore on March 2019 to ₹ 19309 crore on March 2024 . This represents a CAGR of 11.59% over 6 years. .
  • The Latest Trading Price of Alembic Pharmaceuticals Ltd is ₹ 1124 as of 04 Nov 15:30.

Historical Market Cap of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Company Fundamentals for Alembic Pharmaceuticals Ltd

No data available

Image

Alembic Pharmaceuticals Ltd

NSE: APLLTD

PRICE

1124.65

3.25 (0.29%)

stock direction

Last updated on: Nov 04 03:30 PM

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Alembic Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 20241124.65
01 Nov 20241121.4
31 Oct 20241128.75
30 Oct 20241083.3
29 Oct 20241061.6
28 Oct 20241074.2
25 Oct 20241068.5
24 Oct 20241066.8
23 Oct 20241085.35
22 Oct 20241090.7

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Alembic Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Alembic Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Alembic Pharmaceuticals Ltd

No data available

Historical P/E Ratio of Alembic Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Alembic Pharmaceuticals Ltd

No data available

* All values are in %

About Alembic Pharmaceuticals Ltd

  • Alembic Pharmaceuticals manufactures and markets generic pharmaceutical products all over the world.
  • The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Ltd was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Ltd. The company is engaged in pharmaceuticals business.
  • As per the scheme of arrangement, the 'Pharmaceutical Undertaking' of the Alembic Ltd was demerged and transferred to the company with effect from appointed date, April 1, 2010. In April 15, 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharma gets USFDA nod for hypertension treatment drug

The said drug is therapeutically equivalent to the reference listed drug product (RLD), Di...

Read more

21 Oct 202411:23

News

Alembic Pharmaceuticals to discuss results

Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 ...

Read more

18 Oct 202417:20

News

Alembic Pharma's oncology formulations unit successfully completes USFDA inspection

Alembic Pharmaceuticals has successfully completed the United States Food and Drug Adminis...

Read more

09 Oct 202409:16

News

Alembic Pharma rises after oncology facility completes US FDA audit with 'zero' observations

The US FDA had conducted an inspection at the company's oncology (injectable and oral soli...

Read more

09 Oct 202409:21

News

Alembic Pharma gets US FDA nod for antihistamine Alcaftadine ophthalmic solution

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

04 Oct 202409:29

News

Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration...

Read more

03 Oct 202409:23

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Alembic Pharmaceuticals Ltd Market Cap

What is the market cap of Alembic Pharmaceuticals Ltd?

As of November 5, 2024, Alembic Pharmaceuticals Ltd has a market capitalization of ₹22106.47, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Alembic Pharmaceuticals Ltd's market capitalization?

Alembic Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Alembic Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Alembic Pharmaceuticals Ltd's market capitalization change?

Alembic Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*